Personal information

Countries

Japan

Activities

Collapse all

Employment (1)

Otsuka Pharmaceutical Co., Ltd.: Tokyo, JP

Employment
Source: Self-asserted source
Sakiko Yamada

Works (6)

A multicenter, single‐arm, open‐label interventional study of adherence to brexpiprazole during switching from previous antipsychotic drugs in patients with schizophrenia or schizoaffective disorder

Neuropsychopharmacology Reports
2024-03 | Journal article
DOI: 10.1002/npr2.12416
Contributors: Kazuyuki Nakagome; Hisateru Tachimori; Shiro Endo; Ken Murakami; Takaharu Azekawa; Seiji Hongo; Kazunari Niidome; Yoshitsugu Kojima; Sakiko Yamada; Hideki Oi et al.
Source: check_circle
Crossref

Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study

Advances in Therapy
2022-09 | Journal article
DOI: 10.1007/s12325-022-02252-9
Contributors: Akitoyo Hishimoto; Norio Yasui-Furukori; Daisuke Sekine; Miyuki Matsukawa; Sakiko Yamada
Source: check_circle
Crossref

Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study

Human Psychopharmacology: Clinical and Experimental
2021-07 | Journal article
DOI: 10.1002/hup.2777
Contributors: Jun Ishigooka; Ken Inada; Kazunari Niidome; Kazuo Aoki; Yoshitsugu Kojima; Shuichi Iwashita; Sakiko Yamada
Source: check_circle
Crossref

Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database

Neuropsychiatric Disease and Treatment
2021-03 | Journal article
DOI: 10.2147/NDT.S299005
Contributors: Takeshi Inoue; Hiromi Sano; Yoshitsugu Kojima; Sakiko Yamada; Osamu Shirakawa
Source: check_circle
Crossref

<p>Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective</p>

Drug Design, Development and Therapy
2020-12 | Journal article
DOI: 10.2147/DDDT.S240859
Contributors: Yoshinori Watanabe; Sakiko Yamada; Tempei Otsubo; Toshiaki Kikuchi
Source: check_circle
Crossref

<p>Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study</p>

Neuropsychiatric Disease and Treatment
2020-10 | Journal article
DOI: 10.2147/NDT.S265173
Contributors: Ken Inada; Sakiko Yamada; Hisashi Akiyoshi; Yoshitsugu Kojima; Shuichi Iwashita; Jun Ishigooka
Source: check_circle
Crossref
How many people are using ORCID?